1. Home
  2. ACRV vs CVU Comparison

ACRV vs CVU Comparison

Compare ACRV & CVU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • CVU
  • Stock Information
  • Founded
  • ACRV 2018
  • CVU 1980
  • Country
  • ACRV United States
  • CVU United States
  • Employees
  • ACRV N/A
  • CVU N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • CVU Military/Government/Technical
  • Sector
  • ACRV Health Care
  • CVU Industrials
  • Exchange
  • ACRV Nasdaq
  • CVU Nasdaq
  • Market Cap
  • ACRV 59.9M
  • CVU 70.2M
  • IPO Year
  • ACRV 2022
  • CVU N/A
  • Fundamental
  • Price
  • ACRV $1.16
  • CVU $3.50
  • Analyst Decision
  • ACRV Strong Buy
  • CVU
  • Analyst Count
  • ACRV 5
  • CVU 0
  • Target Price
  • ACRV $19.75
  • CVU N/A
  • AVG Volume (30 Days)
  • ACRV 1.3M
  • CVU 24.5K
  • Earning Date
  • ACRV 05-20-2025
  • CVU 05-19-2025
  • Dividend Yield
  • ACRV N/A
  • CVU N/A
  • EPS Growth
  • ACRV N/A
  • CVU N/A
  • EPS
  • ACRV N/A
  • CVU 0.26
  • Revenue
  • ACRV N/A
  • CVU $81,078,864.00
  • Revenue This Year
  • ACRV N/A
  • CVU N/A
  • Revenue Next Year
  • ACRV N/A
  • CVU N/A
  • P/E Ratio
  • ACRV N/A
  • CVU $13.15
  • Revenue Growth
  • ACRV N/A
  • CVU N/A
  • 52 Week Low
  • ACRV $1.30
  • CVU $2.16
  • 52 Week High
  • ACRV $10.29
  • CVU $5.85
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 28.93
  • CVU 54.90
  • Support Level
  • ACRV $1.32
  • CVU $3.34
  • Resistance Level
  • ACRV $1.50
  • CVU $3.55
  • Average True Range (ATR)
  • ACRV 0.17
  • CVU 0.17
  • MACD
  • ACRV 0.06
  • CVU 0.03
  • Stochastic Oscillator
  • ACRV 1.55
  • CVU 70.80

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About CVU CPI Aerostructures Inc.

CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.

Share on Social Networks: